These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22258937)

  • 1. Hypermethylation of SHP-1 promoter in patient with high-risk myelodysplastic syndrome and it predicts poor prognosis.
    Zhang Y; Zhao D; Zhao H; Wu X; Zhao W; Wang Y; Xia B; Da W
    Med Oncol; 2012 Dec; 29(4):2359-63. PubMed ID: 22258937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experimental study of SHP-1 promoter methylation in myelodysplastic syndromes and its related mechanism].
    Zhang YZ; Zhao DD; Zhao WP; Zhao HF; Zhao ZG; Wang YF; Wu XX; Han XP; Da WM
    Zhonghua Xue Ye Xue Za Zhi; 2012 Feb; 33(2):108-12. PubMed ID: 22730659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship between SHP-1 gene methylation and STAT3 phosphorylation and prognosis in patients with myelodysplastic syndrome].
    Han Y; Zhang J; Ji J; Pang YB; Hua LM; Shao ZH
    Zhonghua Yi Xue Za Zhi; 2019 Sep; 99(36):2811-2815. PubMed ID: 31550807
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of Src homology region 2 domain-containing phosphatase-1 hypermethylation in the classification of patients with myelodysplastic syndromes and its association with signal transducer and activator of transcription 3 phosphorylation in skm-1 cells.
    Han Y; Zhang J; Pang Y; Wang Y; Zhang X; Zhang H
    J Int Med Res; 2021 Mar; 49(3):300060521999550. PubMed ID: 33736531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal methylation of the sex-determining region Y-box 17 (SOX17) promoter predicts poor prognosis in myelodysplastic syndrome.
    Fan R; Zhao XL; Wang H; He HY; Peng ZP; Yang B; Han T; Wang W; Wang XQ; Lin GW
    Clin Lab; 2014; 60(9):1465-74. PubMed ID: 25291942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive activation of STAT3 in Sézary syndrome is independent of SHP-1.
    McKenzie RC; Jones CL; Tosi I; Caesar JA; Whittaker SJ; Mitchell TJ
    Leukemia; 2012 Feb; 26(2):323-31. PubMed ID: 21818116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic relevance of aberrant SOCS-1 gene promoter methylation in myelodysplastic syndromes patients.
    Chaubey R; Sazawal S; Mahapatra M; Chhikara S; Saxena R
    Int J Lab Hematol; 2015 Apr; 37(2):265-71. PubMed ID: 25123164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant methylation of the negative regulators RASSFIA, SHP-1 and SOCS-1 in myelodysplastic syndromes and acute myeloid leukaemia.
    Johan MF; Bowen DT; Frew ME; Goodeve AC; Reilly JT
    Br J Haematol; 2005 Apr; 129(1):60-5. PubMed ID: 15801956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of aberrant p73 promoter methylation in patients with myelodysplastic syndrome].
    Zhao YS; Yang R; Gu SC; Guo J; Zhang X; Wu LY; Li X; Chang CK
    Zhonghua Xue Ye Xue Za Zhi; 2012 Oct; 33(10):847-51. PubMed ID: 23384909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter methylation attenuates SHP1 expression and function in patients with primary central nervous system lymphoma.
    Liu J; Wang Y; Sun X; Ji N; Sun S; Wang Y; Liu F; Cui Q; Wang C; Liu Y
    Oncol Rep; 2017 Feb; 37(2):887-894. PubMed ID: 27959415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation of the CpG island near SOX7 gene promoter is correlated with the poor prognosis of patients with myelodysplastic syndrome.
    Fan R; Zhang LY; Wang H; Yang B; Han T; Zhao XL; Wang W; Wang XQ; Lin GW
    Tohoku J Exp Med; 2012 Jun; 227(2):119-28. PubMed ID: 22706399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter hypermethylation of p15INK4B, HIC1, CDH1, and ER is frequent in myelodysplastic syndrome and predicts poor prognosis in early-stage patients.
    Aggerholm A; Holm MS; Guldberg P; Olesen LH; Hokland P
    Eur J Haematol; 2006 Jan; 76(1):23-32. PubMed ID: 16343268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation of Wnt antagonist genes: a useful prognostic marker for myelodysplastic syndrome.
    Wang H; Fan R; Wang XQ; Wu DP; Lin GW; Xu Y; Li WY
    Ann Hematol; 2013 Jan; 92(2):199-209. PubMed ID: 23093371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation of DAPK1 promoter: frequent but not an adverse prognostic factor in myelodysplastic syndrome.
    Qian J; Yao DM; Lin J; Wang YL; Han LX; Xu WR; Wu CY
    Int J Lab Hematol; 2010 Feb; 32(1 Pt 2):74-81. PubMed ID: 19196380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant methylation of DNA-damage-inducible transcript 3 promoter is a common event in patients with myelodysplastic syndrome.
    Lin J; Wang YL; Qian J; Yao DM; Zhu ZH; Qian Z; Xu WR
    Leuk Res; 2010 Aug; 34(8):991-4. PubMed ID: 20116099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing SHP-1 expression with 5-azacytidine may inhibit STAT3 activation and confer sensitivity in lestaurtinib (CEP-701)-resistant FLT3-ITD positive acute myeloid leukemia.
    Al-Jamal HA; Mat Jusoh SA; Hassan R; Johan MF
    BMC Cancer; 2015 Nov; 15():869. PubMed ID: 26547689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Methylation status of ZO-1 gene in patients with myelodysplastic syndrome].
    Kang HY; Wang C; Dou LP; Qing Y; Han XP; Sun JF; Liu CH; Lu XC; Liu Y; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):70-3. PubMed ID: 18315903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative comparison of CDKN2B methylation in pediatric and adult myelodysplastic syndromes.
    Kim M; Kook H; Park HJ; Ahn HS; Lee KC; Lee KS; Park SK; Lim JY; Kim HK; Han DK; Lee DS;
    Acta Haematol; 2013; 130(2):115-21. PubMed ID: 23571652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of p21 in myelodysplastic syndrome is associated with p73 promoter hypermethylation and indicates poor prognosis.
    Zhao Y; Guo J; Zhang X; Zhang Z; Gu S; Fei C; Li X; Chang C
    Am J Clin Pathol; 2013 Dec; 140(6):819-27. PubMed ID: 24225749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SOX7 methylation is an independent prognostic factor in myelodysplastic syndromes.
    Xu ZJ; Tang CY; Zhou JD; Ma JC; Wen XM; Deng ZQ; Leng JY; Qiu ZY; Qian J; Lin J
    Pathol Res Pract; 2019 Feb; 215(2):322-328. PubMed ID: 30554866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.